Publications found:
369
Sort by:
Next Generation Immunotherapies Market 2026
US$ 2,999.00
The Next Generation Immunotherapies Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
December 2025
200 pages
Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report, By Product (Media, Sera, Antibodies, Reagents & Buffers), By End Use (CROs & CMOs, Biopharmaceutical & Pharmaceutical Companies), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cell therapy raw materials market size was estimated at USD 5.47 billion in 2025 and is projected to reach USD 21.88 billion by 2033, growing at a CAGR of 19.15% from 2026 to 2033. Innovat...
December 2025
150 pages
Global Plasma-Derived Therapeutics Market - 2023-2033
US$ 2,999.00
The Global Plasma-Derived Therapeutics Market was valued at US$ 20.16 Billion in 2023 and is anticipated to reach US$ 35.10 Billion by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers i...
December 2025
200 pages
Natural Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Serum Albumin, Bovine Serum Albumin, and Plant Serum Albumin), Application (Therapeutic Applications, Drug Delivery, Disease Diagnostics, Research, and Others Applications), and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
US$ 4,450.00
According to our new research study on “Natural Albumin Market Forecast to 2031 –Global Analysis – by Source, Application, and End User,” the market is anticipated to grow from US$ 5.66 billion in 202...
December 2025
236 pages
Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion, Apheresis), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global automated and closed cell therapy processing systems market size was estimated at USD 1.67 billion in 2025 and is projected to reach USD 7.44 billion by 2033, growing at a CAGR of 20.73% f...
December 2025
130 pages
Asia Pacific Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Cell Therapy (Allogeneic, Autologous, Viral Vectors), and Gene Therapy (Non-viral Vectors and Viral Vectors]), Service (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-commercial or R&D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), Transfection Reagents (Polymer-based Transfection Reagents, Lipid-based Transfection Reagents, Viral Transduction Enhancers, and Other Transfection Reagents), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes), and Country
US$ 3,450.00
According to our new research study on “Asia Pacific Cell And Gene Therapy Market Forecast to 2031 –Regional Analysis – by Type, Service, Scale, Service Providers, Transfection Reagents, and End User,...
December 2025
229 pages
Recombinant Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Recombinant Albumin, Bovine Recombinant Albumin, and Others), Application (Excipient in Biotherapeutics And Vaccines, Cell Culture, Drug Delivery, Diagnostics, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Hospitals and Diagnostic Laboratories, and Others)
US$ 4,450.00
According to our new research study on “Recombinant Albumin Market Forecast to 2031 –Global Analysis – by Application and End User,” the market is anticipated to grow from US$ 392.50 million in 2024 t...
December 2025
237 pages
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Exosome Type (Natural, Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Exosome Therapeutics Market, valued at USD 32.63 Million in 2024, is projected to experience a CAGR of 41.56% to reach USD 262.58 Million by 2030. Exosome therapeutics involve the utilizati...
November 2025
180 pages
T-cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based)), By Indication (Hematologic Malignancies, Solid Tumors, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global T-cell Therapy Market, valued at USD 2.92 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 5.14 Billion by 2030. T-cell therapy represents a specialized form of immu...
November 2025
183 pages
Adalimumab Market - 2021
US$ 2,999.00
The Adalimumab Market was valued at USD 3829.40 million in 2021 and is anticipated to reach by , at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
November 2025
223 pages
Blood Clotting Factors Market 2026
US$ 2,999.00
The Blood Clotting Factors Market was valued at in and is anticipated to reach by , at a CAGR of 0.069 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
200 pages
Blood Plasma Derivatives Market 2026
US$ 2,999.00
The Blood Plasma Derivatives Market was valued at in and is anticipated to reach by , at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
217 pages
Cytokine-based Therapeutics Market 2026
US$ 2,999.00
The Cytokine-based Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
223 pages
Erythropoietin Stimulating Agents Market - 2022-2030
US$ 2,999.00
The Erythropoietin Stimulating Agents Market was valued at USD 9.8 billion in 2022 and is anticipated to reach USD 19.2 billion by 2030, at a CAGR of 0.089 from 2026 to 2032. The report delivers in-de...
November 2025
207 pages
Fusion Proteins Market 2026
US$ 2,999.00
The Fusion Proteins Market was valued at in and is anticipated to reach by , at a CAGR of 0.105 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
207 pages
Immunology Drugs Market - 2024-2033
US$ 2,999.00
The Immunology Drugs Market was valued at US$ 122.40 Billion in 2024 and is anticipated to reach US$ 262.01 Billion by 2033, at a CAGR of 0.088 from 2026 to 2032. The report delivers in-depth insights...
November 2025
217 pages
Inter-alpha-inhibitor Proteins Market 2026
US$ 2,999.00
The Inter-alpha-inhibitor Proteins Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
200 pages
Interferon Drugs Market 2026
US$ 2,999.00
The Interferon Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
210 pages
Interferons Market 2026
US$ 2,999.00
The Interferons Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
200 pages
Plasma Protein Therapeutics Market 2026
US$ 2,999.00
The Plasma Protein Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
219 pages
Recombinant Plasma Protein Therapeutics Market - 2023-2031
US$ 2,999.00
The Recombinant Plasma Protein Therapeutics Market was valued at US$ 34,774.78 million in 2023 and is anticipated to reach US$ 56,267.88 million by 2031, at a CAGR of 0.062 from 2026 to 2032. The repo...
November 2025
210 pages
Tumor Necrosis Factor Inhibitor Drugs Market 2026
US$ 2,999.00
The Tumor Necrosis Factor Inhibitor Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.163 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
219 pages
Nanobodies Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type (Mono-Specific, Multi-Specific) By Application (Acquired Thrombotic Thrombocytopenic Purpura (TTP), Respiratory Syncytial Virus Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others) By End User (Pharmaceutical & Biotechnology Companies, Research Laboratories, and Others), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Nanobodies Market, valued at USD 578.40 Million in 2024, is projected to experience a CAGR of 18.30% to reach USD 1585.39 Million by 2030. Nanobodies, also known as single-domain antibodies...
November 2025
183 pages
CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global CAR-T Cell Therapy Market, valued at USD 3.87 Billion in 2024, is projected to experience a CAGR of 22.77% to reach USD 13.25 Billion by 2030. Chimeric Antigen Receptor (CAR)-T cell therapy...
November 2025
182 pages
Human Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application [Therapeutic Applications (Liver and Kidney Diseases, Surgery, Hypovolemia and Hypoalbuminemia, and Others), Drug Delivery, Disease Diagnostics, Research, and Others], and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
US$ 4,450.00
According to our new research study on “Human Albumin Market Forecast to 2031 -Global Analysis - by Application and End User,” the market is anticipated to grow from US$ 4.68 billion in 2024 to US$ 6....
November 2025
260 pages
Cardiovascular Biologics Market - 2024-2033
US$ 2,999.00
The Cardiovascular Biologics Market was valued at US$ 2.20 Billion in 2024 and is anticipated to reach US$ 4.23 Billion by 2033, at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth insi...
November 2025
186 pages
Inflammatory Diseases Biologics Market - 2024-2033
US$ 2,999.00
The Inflammatory Diseases Biologics Market was valued at US$ 99.06 Billion in 2024 and is anticipated to reach US$ 157.31 Billion by 2033, at a CAGR of 0.053 from 2026 to 2032. The report delivers in-...
November 2025
213 pages
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), By Product, By Payload, By Technology, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global antibody drug conjugates market size was estimated at USD 12.26 billion in 2024 and is projected to reach USD 32.11 billion by 2033, growing at a CAGR of 10.49% from 2025 to 2033. This grow...
November 2025
150 pages
U.S. Biologics Contract Development Market Size, Share, & Trends Analysis Report By Source (Mammalian, Microbial), By Product Service (Cell-line Development, Process Development), By Indication, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The U.S. biologics contract development market size was estimated at USD 2.82 billion in 2024 and is projected to reach USD 4.48 billion by 2033, growing at a CAGR of 5.3% from 2025 to 2033. Factors s...
October 2025
100 pages
Global Biological Drugs Market Growth 2025-2031
US$ 3,660.00
The global Biological Drugs market size is predicted to grow from US$ 357780 million in 2025 to US$ 583920 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031. The impact of th...
October 2025
115 pages
Plasma Fractionation Market 2026
US$ 2,999.00
The Plasma Fractionation Market was valued at in and is anticipated to reach by , at a CAGR of 0.07 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
October 2025
220 pages
Global Biologics Market - 2025 -2033
US$ 4,350.00
Global Biologics Market: Industry Outlook The global biologics market reached US$ 472.71 billion in 2023, with a rise of US$ 512.25 billion in 2024, and is expected to reach US$ 966.98 billion by 2033...
October 2025
180 pages
Global Biologics Outsourcing Market - 2025 -2033
US$ 4,350.00
Global Biologics Outsourcing Market: Industry Outlook The global biologics outsourcing market reached US$ 20.10 billion in 2023, with a rise of US$ 22.92 billion in 2024, and is expected to reach US$...
October 2025
180 pages
Global Bispecific Mabs Market - 2025 -2033
US$ 4,350.00
Bi-Specific MAbs Market Size& Industry Outlook The global Bi-Specific MAbs market size reached US$ 4.82Billion with rise of US$5.51Billion in 2024 is expected to reach US$ 15.43 Billion by 2033, growi...
October 2025
180 pages
Global Multispecific Antibodies Market - 2025 -2033
US$ 4,350.00
Multispecific Antibodies Market Size The global multispecific antibodies market size reached US$ 12.61 Billion in 2024 from US$ 10.19 billion in 2023 and is expected to reach US$ 98.45 Billion by 2033...
October 2025
180 pages
Protein Therapeutics Market - 2024-2033
US$ 2,999.00
The Protein Therapeutics Market was valued at US$ 371.13 billion in 2024 and is anticipated to reach US$ 657.12 billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insi...
September 2025
210 pages
Biologics & Biosimilars Market Forecasts to 2032 – Global Analysis By Product Type (Biologics, Biosimilars), Therapeutic Area (Oncology, Ophthalmology, Autoimmune Disorders, Cardiovascular, Endocrinology, Infectious Diseases, Hematology, and Wound Healing & Regenerative Care), Manufacturing Source, Distribution Channel, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Biologics & Biosimilars Market is accounted for $538.20 billion in 2025 and is expected to reach $1219.86 billion by 2032 growing at a CAGR of 12.4% during the...
September 2025
200 pages
Biologics Market Size, Share, Trends and Forecast by Source, Product, Disease, Manufacturing, and Region, 2025-2033
US$ 2,999.00
The global biologics market size was valued at USD 377.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 769.7 Billion by 2033, exhibiting a CAGR of 7.38% from 2025-203...
September 2025
149 pages
Biologics Outsourcing Market - 2023-2033
US$ 2,999.00
The Biologics Outsourcing Market was valued at US$ 20.10 billion in 2023 and is anticipated to reach US$ 64.57 billion by 2033, at a CAGR of 0.121 from 2026 to 2032. The report delivers in-depth insig...
September 2025
200 pages
Immunology & Inflammatory Diseases Drugs Market - 2024-2033
US$ 2,999.00
The Immunology & Inflammatory Diseases Drugs Market was valued at US$ 212.76 Billion in 2024 and is anticipated to reach US$ 431.11 Billion by 2033, at a CAGR of 0.082 from 2026 to 2032. The report de...
August 2025
243 pages
